Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus
Journal Article
·
· Journal of Clinical Endocrinology and Metabolism
- Harvard Medical School, Boston, MA (United States)
The retinoblastoma tumor suppressor gene (RB1) is inactivated in hereditary and sporadic forms of retinoblastoma as well as in a number of other sporadic tumors. The majority of human pituitary tumors have been shown to be monoclonal neoplasms, suggesting that 1 or more somatic mutations are involved in the clonal expansion of a single progenitor cell. Recently, a high percentage of transgenic mice containing a disrupted RB1 allele have been shown to develop pituitary tumors. To investigate whether RB1 inactivation contributes to the development of human pituitary adenomas, the authors searched for loss of heterozygosity (LOH) within the RB1 gene locus in a variety of human pituitary adenomas. They screened 34 adenomas for LOH using a polymerase chain reaction (PCR)-based microsatellite polymorphic marker at the RB1 gene locus. In addition, a variable number of tandem repeat markers from within the RB1 gene was also used to search for LOH in 14 tumors. They found no LOH or microsatellite instability at the RB1 locus in any of the informative cases (30 of 34). Additionally, they showed that 4 representative adenomas from female patients are monoclonal in origin using a PCR-based clonality analysis assay. They conclude that the RB1 gene shows no LOH in a variety of human pituitary adenomas and that PCR-based microsatellite markers can serve as a useful tool for LOH analysis in human pituitary tumors. 42 refs., 3 figs., 1 tab.
- OSTI ID:
- 54553
- Journal Information:
- Journal of Clinical Endocrinology and Metabolism, Journal Name: Journal of Clinical Endocrinology and Metabolism Journal Issue: 4 Vol. 78; ISSN JCEMAZ; ISSN 0021-972X
- Country of Publication:
- United States
- Language:
- English
Similar Records
The retinoblastoma gene in human pituitary tumors
Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus
Molecular screening of pituitary adenomas for gene mutations and rearrangements
Journal Article
·
Wed Sep 01 00:00:00 EDT 1993
· Journal of Clinical Endocrinology and Metabolism; (United States)
·
OSTI ID:5045219
Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus
Journal Article
·
Sun Oct 01 00:00:00 EDT 1995
· Journal of Clinical Endocrinology and Metabolism
·
OSTI ID:443621
Molecular screening of pituitary adenomas for gene mutations and rearrangements
Journal Article
·
Thu Jul 01 00:00:00 EDT 1993
· Journal of Clinical Endocrinology and Metabolism; (United States)
·
OSTI ID:5412165